# Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

> **NCT05785949** · NA · TERMINATED · sponsor: **Geistlich Pharma AG** · enrollment: 75 (actual)

## Conditions studied

- Cartilage Defects

## Interventions

- **PROCEDURE:** Microfracture
- **DEVICE:** Chondro-Gide bilayer collagen membrane

## Key facts

- **NCT ID:** NCT05785949
- **Lead sponsor:** Geistlich Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-10
- **Primary completion:** 2025-12-04
- **Final completion:** 2026-01-31
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** The study was terminated early due to a change in business strategy at the sponsor, unrelated to any safety concerns with the medical device.
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785949, "Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05785949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*